Centrifugal System Concentrates PRP from Blood 
|
By HospiMedica International staff writers Posted on 02 Mar 2020 |
|
Image: Post centrifugation (R) and the separated PRP aliquot (L) (Photo courtesy of EmCyte Corporation)
An autologous biologic concentrating system allows the safe and rapid preparation of platelet rich plasma (PRP) from a small sample of blood at the point of care.
The EmCyte Corporation (Fort Myers, FL, USA) PurePRP Supraphysiologic Concentrating System is based a double spin centrifugal system designed to be used for the safe and rapid preparation of autologous PRP from a 30 to 120mL sample of the patient’s blood. Following six and a half minutes of processing time, the system can deliver up to 95% platelet yield and nine-fold concentration into a 7-8 mL sample of PRP, without any red blood cell (RBC) content. The resulting supraphysiologic PRP is then aspirated from the container with a syringe.
The extracted PRP, which contains viable growth factors, non-inflammatory mediators, and cytokines, is then used on its own, or mixed with a blend of autograft and allograft bone prior to application to the designated surgical site in order to improve bone graft handling characteristics. The cell composition offers a powerful and viable boost to local tissue environment, making it an effective and well tolerated treatment application. Closed system processing and superior handling offer optimal sterility control and patient safety.
“Autologous regenerative medicine is fast becoming a standard of care and using the right biologic is vitally important to how patients respond. The PurePRP Supraphysiologic Concentrating System is the next step in clinical excellence,” said Patrick Pennie, President and CEO of EmCyte Corporation. “We believe we've hit the mark on this innovation after improving the clinical experience for both the practitioner and patient.”
PRP preparation involves the collection of the patient's whole blood which undergoes centrifugation to separate the PRP aliquot from platelet-poor plasma and RBCs, concentrating platelets in rich plasma by a three to nine-fold factor. PRP has been widely investigated and used as a clinical tool for several types of medical treatments, including nerve injury, tendinitis, osteoarthritis, bone repair and regeneration, and plastic and oral surgery.
Related Links:
EmCyte Corporation
The EmCyte Corporation (Fort Myers, FL, USA) PurePRP Supraphysiologic Concentrating System is based a double spin centrifugal system designed to be used for the safe and rapid preparation of autologous PRP from a 30 to 120mL sample of the patient’s blood. Following six and a half minutes of processing time, the system can deliver up to 95% platelet yield and nine-fold concentration into a 7-8 mL sample of PRP, without any red blood cell (RBC) content. The resulting supraphysiologic PRP is then aspirated from the container with a syringe.
The extracted PRP, which contains viable growth factors, non-inflammatory mediators, and cytokines, is then used on its own, or mixed with a blend of autograft and allograft bone prior to application to the designated surgical site in order to improve bone graft handling characteristics. The cell composition offers a powerful and viable boost to local tissue environment, making it an effective and well tolerated treatment application. Closed system processing and superior handling offer optimal sterility control and patient safety.
“Autologous regenerative medicine is fast becoming a standard of care and using the right biologic is vitally important to how patients respond. The PurePRP Supraphysiologic Concentrating System is the next step in clinical excellence,” said Patrick Pennie, President and CEO of EmCyte Corporation. “We believe we've hit the mark on this innovation after improving the clinical experience for both the practitioner and patient.”
PRP preparation involves the collection of the patient's whole blood which undergoes centrifugation to separate the PRP aliquot from platelet-poor plasma and RBCs, concentrating platelets in rich plasma by a three to nine-fold factor. PRP has been widely investigated and used as a clinical tool for several types of medical treatments, including nerve injury, tendinitis, osteoarthritis, bone repair and regeneration, and plastic and oral surgery.
Related Links:
EmCyte Corporation
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Hemodynamic Monitoring Sensor
FloTrac
New
Endoscopic Suturing System
OverStitch
Latest Surgical Techniques News
- Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
- Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
- Spectroscopy Technique Improves Surgery for Pediatric Epilepsy Patients
- Bioengineered Arteries Show Promise for Cardiovascular Surgery
- Online Tool Guides Surgical Decisions for Gallbladder Cancer
- Innovative Technology Enables Rapid Life-Saving Surgical Leak Detection
- First-Of-Its-Kind Bioresorbable Implant to Help Children with Rare Respiratory Disease
- Screw-Shaped Magnetic Microrobots to Transform Treatment for Patients with Inoperable Blood Clots
- "Ultra-Rapid" Testing in the OR Could Enable Accurate Removal of Brain Tumors
- Automated Endoscopic Device Obtains Improved Biopsy Results in Single Pass
- World's First Machine Learning Model Combats Wrong-Site Surgery
- Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk
- New Surface Coating Could Prevent Blood Clotting in Medical Devices and Implants
- Dumbbell-Shaped Thrombectomy Device Offers Novel Approach to Cerebral Venous Sinus Thrombosis Treatment
- Novel Catheter Mimics Snake Teeth to Grab Blood Clots
- New Laparoscopic Imaging Technique Accurately Maps Biological Tissue for Minimally Invasive Surgery
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreCritical Care
view channel
Novel Coating Significantly Extends Longevity of Implantable Biosensors
Wearable and implantable biosensors capable of accurately detecting biological molecules in a non-invasive or minimally invasive way offer enormous potential for monitoring patients’ health and their responses... Read more
Nanogel-Based Drug Delivery Technology to Improve UTI Treatment
Urinary tract infections (UTIs) are not only widespread and costly but also highly debilitating, significantly impacting the quality of life for those affected. The antibiotics commonly used to treat UTIs... Read more
New IV Pole Improves Safety and Ease of Administering IV Medications at Hospital Bedside
Preventable medication errors affect around 500,000 hospitalized patients in the U.S. every year. A significant portion of these errors occur with intravenous (IV) smart pumps, which require a precise... Read more
Patient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Point of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more
